Goyang, South Korea

Won Jun Kang


Average Co-Inventor Count = 9.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Goyang-si, KR (2016)
  • Goyang, KR (2020)

Company Filing History:


Years Active: 2016-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Won Jun Kang in Cancer Treatment**

Introduction

Won Jun Kang is a notable inventor based in Goyang, South Korea, recognized for his significant contributions to cancer research through his innovative inventions. With a total of two patents, Kang is dedicated to developing advanced therapies that target specific cancer biomarkers.

Latest Patents

Kang's most recent patents include the invention titled "Glypican-3 specific aptamer and use thereof." This invention focuses on a DNA aptamer that selectively binds to the Glypican-3 (GPC3) protein, which is associated with hepatocellular carcinoma. The invention also includes compositions designed for cancer treatment and diagnosis, emphasizing the potential therapeutic applications of this aptamer.

Another critical patent from Kang is "Aptamer which selectively binds to the ERBB2 receptor and uses thereof.” This patent discloses a DNA aptamer that targets the Her2 (ERBB2) receptor, which plays a significant role in breast cancer development. The invention outlines compositions intended for cancer metastasis suppression and diagnosis, showcasing a novel approach that differs from conventional antibody techniques.

Career Highlights

Throughout his career, Won Jun Kang has been affiliated with reputable organizations such as the POSTECH Academy-Industry Foundation and the Korea Food & Drug Administration. His work within these institutions has facilitated his research and contributed to the advancement of cancer treatment methodologies.

Collaborations

Kang has collaborated with esteemed colleagues in his field, including Jung Hwan Lee and Jong In Kim. Their joint efforts have further driven innovation and research in the realm of cancer diagnostics and therapeutics.

Conclusion

Won Jun Kang's inventive work in developing specific aptamers represents a vital advancement in cancer treatment and diagnostics. His patents not only highlight his commitment to addressing complex health issues but also signify an important step forward in biomedical innovation, offering hope for improved therapies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…